Targeting hsp90 family members: A strategy to improve cancer cell death

Pedro Buc Calderon1, Raphaël Beck2, Christophe Glorieux2

  • 1Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Belgium; Facultad de Ciencias de la Salud, Universidad Arturo Prat, Iquique, Chile.

Insights

Heat shock protein 90 (Hsp90) chaperones are vital for protein folding. Targeting Hsp90, particularly through oxidative cleavage, can disrupt cancer cell machinery, leading to protein degradation and potential therapeutic benefits.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • Protein folding is essential for cellular function, converting genetic information into functional proteins.
  • Protein chaperones, like Hsp90, are critical for achieving correct three-dimensional protein conformations.
  • Dysregulation of protein folding is implicated in various diseases, including cancer.

Purpose of the Study:

  • To review strategies targeting Hsp90 family members for cancer therapy.
  • To elucidate the consequences of Hsp90 disruption, specifically oxidative cleavage.
  • To explore the therapeutic potential of modulating Grp94 expression in cancer.

Main Methods:

  • Review of existing literature on Hsp90 function and targeting.
  • Analysis of mechanisms involving Hsp90 oxidative cleavage at the N-terminal nucleotide-binding site.
  • Discussion of Grp94 (an Hsp90 family member) expression modulation.

Main Results:

  • Disruption of Hsp90 machinery leads to client protein degradation.
  • Oxidative cleavage of Hsp90 at its N-terminal nucleotide-binding site is a key mechanism.
  • Modulating Grp94 expression presents a potential strategy to reduce cancer recurrence.

Conclusions:

  • Targeting Hsp90 offers a promising avenue for increasing cancer cell death.
  • Understanding Hsp90's role in protein homeostasis is crucial for developing novel cancer therapies.
  • Modulating Grp94 may be a valuable therapeutic goal to prevent cancer relapses.

Related Concept Videos

Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.9K
Gene Families01:57

Gene Families

3.6K
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
16.7K
Protein Families02:47

Protein Families

4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.6K